| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PAHC over the last quarter tilts toward buying: insiders added a net 10,000 shares worth roughly $318K.
PAHC sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 51.5K | $1.87M | - | |
| Dir | 41.5K | $1.51M | - | |
| COO | 34.5K | $1.25M | - | |
| Other | 14.5K | $528.0K | - | |
| CEO | 3.5K | $126.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2018 | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $46.44 | $1,393,200.00 | -25.5% | |
| Jun 13, 2018 | Bendheim Jack55 | President And CEO | Sell | 30,000 | $46.44 | $1,393,200.00 | -25.5% | |
| Jun 7, 2018 | Bendheim Jack55 | President And CEO | Sell | 30,000 | $46.06 | $1,381,650.28 | -15.8% | |
| Jun 7, 2018 | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $46.06 | $1,381,650.28 | -15.8% | |
| May 18, 2018 | Bfi Co., LLC | 10% Owner | Sell | 9,930 | $45.05 | $447,346.50 | -82.8% | |
| May 18, 2018 | Bendheim Jack55 | President And CEO | Sell | 9,930 | $45.05 | $447,346.50 | -82.8% | |
| Mar 25, 2018 | Bendheim Jack55 | President And CEO | Sell | 2,600 | $45.09 | $117,239.00 | -1.5% | |
| Mar 25, 2018 | Bfi Co., LLC | 10% Owner | Sell | 2,600 | $45.09 | $117,239.00 | -1.5% | |
| Mar 15, 2018 | Bendheim Jack55 | President And CEO | Sell | 24,000 | $40.05 | $961,200.00 | -40.0% | |
| Mar 15, 2018 | Bfi Co., LLC | 10% Owner | Sell | 24,000 | $40.05 | $961,200.00 | -40.0% |